Personnel Information

写真a

YAMOTO Naoki


Job title

Professor(Moving Out or Retirement)

Laboratory Address

1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
To the head of this page.▲

Graduating School 【 display / non-display 】

  • Osaka City University, Faculty of Medicine, Osaka City University Medical School, 1987, Graduated

To the head of this page.▲

Graduate School 【 display / non-display 】

  • Osaka City University, Graduate School, Division of Medicine, Osaka City University Graduate School, Doctor's Course, 1992, Completed

To the head of this page.▲

Degree 【 display / non-display 】

  • MD, PhD, Osaka City University

To the head of this page.▲

Campus Career 【 display / non-display 】

  • 1900.01
    -
    2016.06
    Tokyo Medical and Dental University， (Old Organization)Medical Hospital， Hospital Departments， Department of Neurology, Neurosurgery,Psychiatry and Anesthesiology， Psychiatry， Junior Associate Professor
  • 2021.12
    -
    Now
    Tokyo Medical and Dental University， Professor
To the head of this page.▲

External Career 【 display / non-display 】

  • 1993-1996 Post doctoral fellow, Center for Neurobiology and Behavior, College of Physicians and Surgeons, Columbia University, and New York State Psychiatric Institute,
  • 1996 Resident, Musashi Hospital, National Center of Neurology and Psychiatry,
  • 1996-1998 Post doctoral fellow, National Institute of Neuroscience, National Center of Neurology and Psychiatry,
  • 1998-2002 Section Chief, Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry,
  • 2002-2003 Assistant Professor, Section of Psychiatry and Behavioral Sciences, Tokyo Medical and Dental University Graduate School,
  • 2003- Junior Associate Professor, Section of Psychiatry and Behavioral Sciences, Tokyo Medical and Dental University Medical Hospital,

▼display all

To the head of this page.▲

Academic Society Affiliations 【 display / non-display 】

  • Japanese Society of Psychiatry and Neurology, Japanese Society for Neurochemistry, Japan Neuroscience Society, Japanese Society of Clinical Neuropsychopharmacology, Japanese Society of Schizophrenia Research

To the head of this page.▲

Academic Activity 【 display / non-display 】

  • 2007
    -
    Now
    Japanese Society of Psychiatry and Neurology, Japanese Society for Neurochemistry, Japan Neuroscience Society, Japanese Society of Clinical Neuropsychopharmacology, Japanese Society of Schizophrenia Research Councilor, Japanese Society for Neurochemistry
  • Councilor, Japanese Society for Neurochemistry
To the head of this page.▲

Research Areas 【 display / non-display 】

  • Psychiatry

To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Uezato A, Yamamoto N, Iwayama Y, Hiraoka S, Hiraaki E, Umino A, Haramo E, Umino M, Yoshikawa T, Nishikawa T. Reduced cortical expression of a newly identified splicing variant of the DLG1 gene in patients with early-onset schizophrenia. Transl Psychiatry. 2015; 5 e654. ( PubMed, DOI )

  2. Jitoku D, Yamamoto N, Iwayama Y, Toyota T, Miyagi M, Enokida T, Tasaka Y, Umino M, Umino A, Uezato A, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Kurumaji A, Yoshikawa T, Nishikawa T.. Association study of H2AFZ with schizophrenia in a Japanese case-control sample. J Neural Transm. 2015; 122 (6): 915-923. ( PubMed, DOI )

  3. Yamamoto N, Muraoka S, Kajii Y, Umino A, Nishikawa T.. Identification of a developmentally-regulated and psychostimulant-inducible novel rat gene mrt3 in the neocortex. Eur Neuropsychopharmacol. 2014.10; 24 (10): 1687-1697. ( PubMed, DOI )

  4. Yokoi T, Moriyama M, Hayashi K, Shimada N, Tomita M, Yamamoto N, Nishikawa T, Kyoko Ohno-Matsui. Predictive factors for comorbid psychiatric disorders and their impact on vision-related quality of life in patients with high myopia. Int Ophthalmol. 2014.04; 34 (2): 171-183. ( PubMed, DOI )

  5. Uezato A, Toyofuku A, Umezaki Y, Watanabe M, Toriihara A,Tomita M, Yamamoto N,Kurumaji A, Nishikawa T.. Oral Dysesthesia Rating Scale: a tool for assessing psychosomatic symptoms in oral regions. BMC Psychiatry. 2014; 14 359. ( PubMed, DOI )

  6. Takebayashi T, Yamamoto N, Umino A, Nishikawa T.. Identification of developmentally regulated PCP-responsive non-coding RNA, prt6, in the rat thalamus. PLoS ONE. 2014; 9 (6): e97955. ( PubMed, DOI )

  7. Developmentally regulated and thalamus-selective induction of leiomodin2 gene by a schizophrenomimetic, phencyclidine, in the rat. Int J Neuropsychopharmacol. 2009; 12 1111.

  8. An association analysis of synapse-associated protein 97 (SAP97) gene in schizophrenia. J Neural Transm. 2008; 115 1355.

  9. Sliding doors (but not with beans and tofu). Lancet. 2008; 372 1782.

  10. Effects of schizophrenomimetics on the expression of the CCN1 (CYR61) gene encoding a matricellular protein in the infant and adult neocortex of the mouse and rat. Int J Neuropsychopharmacol. 2007; 4 1.

  11. Selective increase in the extracellular D-serine contents by D-cycloserine in the rat medial frontal cortex. Neurochem Int. 2007; 51 223.

  12. Inhibition of D-serine accumulation in the Xenopus oocyte by expression of the rat ortholog of human 3'-phosphoadenosine 5'-phosphosulfate transporter gene isolated from the neocortex as D-serine modulator-1. J Neurochem. 2006; 96 30.

  13. Evidence for involvement of glial cell activity in the control of extracellular D-serine contents in the rat brain. J Neural Transm. 2006; 113 1717.

▼display all

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. Uezato A, Toyofuku A, Yamamoto N, Kurumaji A, Nishikawa T. Assessing patients with psychosomatic oral dysesthesia (oral cenesthopathy) by Oral DRS. WPA Rregional Congress Osaka Japan 2015 2015.06.05 Osaka

  2. Uezato A, Shimazu D, Jitoku D, Iwayama Y, Toyota T, Yamada K, Yoshikawa T, Yamamoto N, Nishikawa T. . Genetic association and postmortem analyses of papst1, a D-serine modulator in schizophrenia and bipolar disorder.. The 2nd International Conference of D-Amino Acid Research 2014.09.03 Tochigi

  3. Yamamoto N, Takebayashi H, Umino A, Nishikawa T.. Identification of developmentally regulated NMDA receptor antagonist phencyclidine-responsive transcripts in the rat brain.. 29th CINP world congress of neuropsychopharmacology 2014.06.24 Canada

  4. Umino M, Umino A, Yamamoto N, Nishikawa T.. Postnatal development of patterns of basal and schizophrenomimetic phencyclidine-induced gene expression in the rat neocortex.. 29th CINP world congress of neuropsychopharmacology 2014.06.24

To the head of this page.▲